Complex cytogenetic abnormalities in chronic myeloid leukemia resulting in early progression to blast crisis: a case report
Abstract Introduction BCR-ABL1, resulting from t(9;22), is the oncogenic driver of chronic myeloid leukemia and the therapeutic target of the disease. Molecular studies have been the gold standard modality for patient assessment since the advent of tyrosine kinase inhibitor therapy. In spite of that...
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Erthygl |
| Iaith: | English |
| Cyhoeddwyd: |
BMC
2020-11-01
|
| Cyfres: | Journal of Medical Case Reports |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s13256-020-02539-x |